在预测生物标志物的歧视性准确性评估中考虑竞争风险
相关实验视频
Updated: Sep 10, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.2K
Xinran Huang1, Xinyang Jiang1, Ruosha Li1
1Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Statistics in biosciences
|August 25, 2025
概括
随着时间的推移和不同患者群体,生物标志物的表现会有所不同,尤其是在竞争性风险的情况下. 这项研究引入了一种新的回归模型,以准确评估生物标志物的差异性表现,并考虑患者因素和竞争事件.
科学领域:
- 生物统计学
- 流行病学
- 医疗信息学
背景情况:
- 随着时间的推移,生物标志物的分辨性表现可能会发生变化,并且在不同患者小组之间存在差异.
- 评估表现变化对于全面评估生物标志物和识别表现不佳的子群体至关重要.
- 竞争的风险,如死亡,可以混生物标志物对感兴趣的事件的性能评估.
研究的目的:
- 开发一个回归模型来评估共变量如何影响生物标志物的歧视性表现.
- 为了具体评估特定因子的时间依赖的曲线下面面积 (AUC).
- 提供一种在生物标志物性能评估中考虑竞争风险的方法.
主要方法:
- 开发一种新的回归模型来评估对生物标志物的协变效应.
- 伪部分概率的构建,以进行可靠的估计和推断.
- 为拟议的统计估计器建立非对称属性.
主要成果:
- 模拟研究证实了开发的估计器的有限样本性能.
- 拟议的方法已成功应用于非裔美国人病和高血压研究 (AASK) 的现实数据.
结论:
- 开发的回归模型有效地评估了共变量特定的,因果特定的时间依赖的AUC.
- 在存在异质性和竞争风险的情况下,这种方法提供了可靠的生物标志物性能评估方法.
- 这些发现为不同患者群体和复杂的临床情景的生物标志物评估提供了改进的工具.
相关概念视频
Receiver Operating Characteristic Plot
332
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
332
Comparing the Survival Analysis of Two or More Groups
285
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
285
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Strategies for Assessing and Addressing Confounding
155
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
155
Kaplan-Meier Approach
260
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
260

